These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7941961)

  • 1. S-adenosylmethionine blood levels in major depression: changes with drug treatment.
    Bell KM; Potkin SG; Carreon D; Plon L
    Acta Neurol Scand Suppl; 1994; 154():15-8. PubMed ID: 7941961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-adenosylmethionine treatment of depression: a controlled clinical trial.
    Bell KM; Plon L; Bunney WE; Potkin SG
    Am J Psychiatry; 1988 Sep; 145(9):1110-4. PubMed ID: 3046382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of adinazolam and desipramine in the treatment of major depression.
    Kennedy SH; de Groot J; Ralevski E; Reed K
    Int Clin Psychopharmacol; 1991; 6(2):65-76. PubMed ID: 1960382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients.
    Thomas CS; Bottiglieri T; Edeh J; Carney MW; Reynolds EH; Toone BK
    Int Clin Psychopharmacol; 1987 Apr; 2(2):97-102. PubMed ID: 3298421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desipramine plasma concentration and antidepressant response.
    Nelson JC; Jatlow P; Quinlan DM; Bowers MB
    Arch Gen Psychiatry; 1982 Dec; 39(12):1419-22. PubMed ID: 7149903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients.
    Fava M; Rosenbaum JF; Birnbaum R; Kelly K; Otto MW; MacLaughlin R
    Acta Psychiatr Scand; 1992 Jul; 86(1):42-5. PubMed ID: 1414398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression.
    Stewart JW; McGrath PJ; Liebowitz MR; Harrison W; Quitkin F; Rabkin JG
    Arch Gen Psychiatry; 1985 Dec; 42(12):1148-53. PubMed ID: 3907579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies.
    Delle Chiaie R; Pancheri P; Scapicchio P
    Am J Clin Nutr; 2002 Nov; 76(5):1172S-6S. PubMed ID: 12418499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness.
    Stewart JW; Quitkin FM; Liebowitz MR; McGrath PJ; Harrison WM; Klein DF
    Arch Gen Psychiatry; 1983 Feb; 40(2):202-7. PubMed ID: 6337580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of desipramine-refractory depression.
    Nelson JC; Mazure CM; Jatlow PI
    J Clin Psychiatry; 1994 Jan; 55(1):12-9. PubMed ID: 8294386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between plasma desipramine levels and clinical outcome for RDC major depressive inpatients.
    Simpson GM; Pi EH; Abdelmalek E; Boyd JL; Carroll RS; Cooper TB; Miller A
    Psychopharmacology (Berl); 1983; 80(3):240-2. PubMed ID: 6412268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled, prospective study.
    Wroblewski BA; Joseph AB; Cornblatt RR
    J Clin Psychiatry; 1996 Dec; 57(12):582-7. PubMed ID: 9010122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant pharmacotherapy of depression associated with multiple sclerosis.
    Schiffer RB; Wineman NM
    Am J Psychiatry; 1990 Nov; 147(11):1493-7. PubMed ID: 2221162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to desipramine treatment in adolescent major depression.
    Boulos C; Kutcher S; Marton P; Simeon J; Ferguson B; Roberts N
    Psychopharmacol Bull; 1991; 27(1):59-65. PubMed ID: 1862207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.
    Pancheri P; Scapicchio P; Chiaie RD
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):287-94. PubMed ID: 12466028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response?
    Stern SL; Cooper TB; Nelson LD; Johnson MH; Suckow RF
    Int Clin Psychopharmacol; 1996 Dec; 11(4):219-27. PubMed ID: 9031987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response.
    Amsterdam JD; Brunswick DJ; Potter L; Winokur A; Rickels K
    Arch Gen Psychiatry; 1985 Apr; 42(4):361-4. PubMed ID: 3977553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.